Literature DB >> 25250486

Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells.

Motofumi Kumazoe1, Shuntaro Tsukamoto, Connie Lesnick, Neil E Kay, Koji Yamada, Tait D Shanafelt, Hirofumi Tachibana.   

Abstract

Entities:  

Keywords:  67-kDa laminin receptor; apoptosis; chronic lymphocytic leukaemia; phosphodiesterase 5; protein kinase C delta

Mesh：

Substances：

Year:  2014        PMID： 25250486     DOI： 10.1111/bjh.13135

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

Review 1.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 2.  How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme.

Authors:  Mehdi Sanati; Samaneh Aminyavari; Hamid Mollazadeh; Bahram Bibak; Elmira Mohtashami; Amir R Afshari
Journal:  Pharmacol Rep       Date:  2022-01-20       Impact factor: 3.024

3.  Metabolic profiling-based data-mining for an effective chemical combination to induce apoptosis of cancer cells.

Authors:  Motofumi Kumazoe; Yoshinori Fujimura; Shiori Hidaka; Yoonhee Kim; Kanako Murayama; Mika Takai; Yuhui Huang; Shuya Yamashita; Motoki Murata; Daisuke Miura; Hiroyuki Wariishi; Mari Maeda-Yamamoto; Hirofumi Tachibana
Journal:  Sci Rep       Date:  2015-03-31       Impact factor: 4.379

4.  Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells.

Authors:  Yuhui Huang; Motofumi Kumazoe; Jaehoon Bae; Shuhei Yamada; Mika Takai; Shiori Hidaka; Shuya Yamashita; Yoonhee Kim; Yeongseon Won; Motoki Murata; Shuntaro Tsukamoto; Hirofumi Tachibana
Journal:  Oncol Rep       Date:  2015-06-26       Impact factor: 3.906

5.  67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?

Authors:  Nunzia Montuori; Ada Pesapane; Valentina Giudice; Bianca Serio; Francesca W Rossi; Amato De Paulis; Carmine Selleri
Journal:  Transl Med UniSa       Date:  2016-11-01

Review 6.  Phosphodiesterase type 5 and cancers: progress and challenges.

Authors:  Ines Barone; Cinzia Giordano; Daniela Bonofiglio; Sebastiano Andò; Stefania Catalano
Journal:  Oncotarget       Date:  2017-10-12

7.  Hydrogen sulphide donors selectively potentiate a green tea polyphenol EGCG-induced apoptosis of multiple myeloma cells.

Authors:  Jaehoon Bae; Motofumi Kumazoe; Shuya Yamashita; Hirofumi Tachibana
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

8.  Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation.

Authors:  Usama A Fahmy
Journal:  Drug Des Devel Ther       Date:  2015-11-18       Impact factor: 4.162

9.  Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.

Authors:  Pan Pantziarka; Vidula Sukhatme; Sergio Crispino; Gauthier Bouche; Lydie Meheus; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2018-04-11

10.  Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range.

Authors:  William Hankey; Benjamin Sunkel; Fuwen Yuan; Haiyan He; Jennifer M Thomas-Ahner; Zhong Chen; Steven K Clinton; Jiaoti Huang; Qianben Wang
Journal:  Transl Oncol       Date:  2020-05-23       Impact factor: 4.803
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.